InGeneron Completes Strategic Financing from Sanford Health to Advance Regenerative Cell Therapies
InGeneron Announces Presentation of Results from Investigator Initiated Case Series of its Regenerative Cell Therapy in Chronic Back Pain at IFATS
In the US InGeneron’s Transpose® RT cell therapy platform is for investigational use only. By Clicking ‘Continue’ I confirm acknowledgment
